KFA Browser > Bevacizumab 25 mg/mL Cairan Injeksi Untuk Infus (BEVAGEN)

Bevacizumab 25 mg/mL Cairan Injeksi Untuk Infus (BEVAGEN)

  1. General Information
  2. Sales Information
  3. Anatomical Therapeutic Chemical Group
  4. Identifier Reference
  5. Actual Medicinal Product (POAK)
  6. Ingredients
  7. Product Hierarchy
KFA Code (PV) 93012890
Type Obat
Unit of Measure (UCUM) milliliter
Smallest Logistic Unit Vial
Dosage Form Larutan Injeksi
Drug Classification Obat Keras
Route Administration Intravena Injeksi (ke pembuluh darah)
NIE BPOM DKL2457901749A1
Trade Name BEVAGEN
Manufacturer ETANA BIOTECHNOLOGIES INDONESIA
Registrar ETANA BIOTECHNOLOGIES INDONESIA
Chemical Substance (INN) L01FG01 - Bevacizumab
Anatomical Main Group L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Therapectic Subgroup L01 - ANTINEOPLASTIC AGENTS
Pharmacological Subgroup L01F - MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Chemical Subgroup L01FG - VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
Alternative Name (USAN) bevacizumab
Kamus Farmalkes (KFA – IHS) 93012890 - Bevacizumab 25 mg/mL Cairan Injeksi Untuk Infus
NIE BPOM DKI2263800149A1 - BEVAGEN
LKPP 74887742 - Bevacizumab/Bevasizumab 100 mg/4 mL
NIE BPOM DKL2457901749A1 - BEVAGEN
LKPP 78389314 - Bevacizumab/Bevasizumab 100 mg/4 mL.
Name Display Name Dosage

false

false

25 mg
KFA Code (PV) Pack Type Estimated Pack Price (IDR)
94023366 Dus isi 1 2.450.000,00

Product Hierarchy